RECRUITING • Phase NA • Stage 0, I, II, III, IV • Post-Menopausal • Interventional
The following is imported from ClinicalTrials.gov:
The purpose of this research is to study the efficacy of a new ultrasound imaging method for diagnosis of breast mass.
Breast Cancer
INTERVENTIONAL
125 participant
November 10, 2021
18 - 999
female
GE Logiq E10 clinical ultrasound scanner
Verasonics research scanner
* adult women ≥ 18 years of age.
* solid breast lesion and ultrasound guided biopsy (either as part of their clinical care or through participation in other irb-approved studies)
* lesion size of 3mm or larger
* \< 18 years of age.
* lacking capacity to consent
* pregnant or lactating
* receiving cancer therapy such as chemotherapy or radiation therapy
RECRUITING
125
03/28/2025
Shigao Chen, PhD
Mayo Clinic
Rochester, Minnesota, United States
© 2025 Outcomes4Me Inc. All rights reserved.